换一批
换一批A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma.
作者：
主题词
成年人(Adult);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);脑肿瘤(Brain Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);DNA甲基化(DNA Methylation);DNA修饰甲基酶类(DNA Modification Methylases);DNA修复酶类(DNA Repair Enzymes);达卡巴嗪(Dacarbazine);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);女(雌)性(Female);随访研究(Follow-Up Studies);胶质母细胞瘤(Glioblastoma);人类(Humans);卡诺夫斯基能力状态(Karnofsky Performance Status);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);全血细胞减少(Pancytopenia);前瞻性研究(Prospective Studies);再手术(Reoperation);时间因素(Time Factors);治疗失败(Treatment Failure);治疗结果(Treatment Outcome);肿瘤抑制蛋白质类(Tumor Suppressor Proteins)
DOI
10.1016/j.ijrobp.2016.11.006
PMID
28011051
发布时间
2022-03-18
- 浏览20
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
